- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01922427
Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery
April 8, 2015 updated by: Revalesio Corporation
Study of RNS60 on Post-operative Pain and Function in Patients Undergoing Knee Anterior Cruciate Reconstruction Surgery
The purpose of this study is to see if use of RNS60 during ACL reconstruction surgery decreases pain and improves functional capacity post-operation.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 2
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of Post-operative pain
Time Frame: 1 week
|
Comparison of scores from validated pain scales from post-surgery to one week
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Primary Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
August 9, 2013
First Submitted That Met QC Criteria
August 12, 2013
First Posted (Estimate)
August 14, 2013
Study Record Updates
Last Update Posted (Estimate)
April 10, 2015
Last Update Submitted That Met QC Criteria
April 8, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07.1.1.H1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Reconstruction
-
Federal University of Health Science of Porto AlegreNot yet recruitingAnterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament Reconstruction RehabilitationBrazil
-
University of Sao Paulo General HospitalUnknownAnterior Cruciate Ligament Reconstruction | Rehabilitation | Anterolateral Ligament ReconstructionBrazil
-
University of ÉvoraFundação para a Ciência e a Tecnologia; Comprehensive Health Research Centre; Hospital da Misericórdia de ÉvoraNot yet recruitingAnterior Cruciate Ligament Reconstruction
-
China Medical University HospitalRecruitingAnterior Cruciate Ligament ReconstructionTaiwan
-
University Medical Centre MariborActive, not recruitingAnterior Cruciate Ligament ReconstructionSlovenia
-
Istituto Ortopedico RizzoliMinistry of Health, ItalyCompletedAnterior Cruciate Ligament ReconstructionItaly
-
Instituto Nacional de RehabilitacionUniversidad Nacional Autonoma de MexicoActive, not recruiting
-
Laval UniversityOrdre Professionnel de la Physiothérapie du Québec (OPPQ)CompletedANTERIOR CRUCIATE LIGAMENT RECONSTRUCTIONCanada
-
University of PittsburghWithdrawnAnterior Cruciate Ligament ReconstructionUnited States
-
University of North Carolina, Chapel HillCompletedAnterior Cruciate Ligament Reconstruction
Clinical Trials on RNS60
-
Revalesio CorporationCompleted
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Craig L Slingluff, JrUniversity of VirginiaCompletedMelanoma | Metastatic Melanoma | Mucosal MelanomaUnited States
-
Revalesio CorporationCompletedSystemic Bioactivity of Nebulized RNS60United Kingdom
-
Mario Negri Institute for Pharmacological ResearchALS Association; Get out ONLUSCompleted
-
Revalesio CorporationCompletedStroke, IschemicUnited States
-
Revalesio CorporationNot yet recruitingAmyotrophic Lateral Sclerosis
-
Revalesio CorporationWithdrawn
-
Revalesio CorporationCompleted
-
Revalesio CorporationWithdrawn